Genomedics maintains a narrowly scoped genomics platform focused on the millegpg product, which handles sensitive genetic and medical data. The observed vulnerability pattern centers on incorrect permission assignment for critical resources, a structural risk in systems managing access to protected health information. Live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Genomedics over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2023-25438HIGH An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files. | May 4, 2023 | 7.8 | 34 | NO | YES |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Genomedics.
Media articles that mention a CVE ID that affects a product developed by Genomedics — matched by CVE ID, not by vendor name.